Philosys Healthcare, COVID-19 (Plasma Therapy/Plasma Therapeutics) Theme Rises 7.05% Up

On the 12th, the COVID-19 (plasma treatment/plasma therapy) theme rose by 3.11% compared to the previous day, showing strength, while Philocis Healthcare, gaining attention as a related stock, surged by 7.05% compared to the previous day. Philocis Healthcare is known as a specialized manufacturer of digital set-top boxes.

[Graph] Major stock price changes in the COVID-19 (plasma treatment/plasma therapy) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Philocis Healthcare's quant financial score is 0.23 points, which is lower in stability, profitability, and growth compared to the average of other stocks related to COVID-19 (plasma treatment/plasma therapy). This can be interpreted as Philocis Healthcare having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, S-Mac ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.